FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating proliferative vitreoretinopathy (PVT) in experiment. For the treatment of PVT, Chinchilla rabbits are exposed to intravitreal introduction of Melfalan once in amount of 0.005 mg in amount of 0.1 ml.
EFFECT: use of the invention enables to obtain an antiproliferative effect in the absence of toxic retinal and retinal pigment epithelial damage.
1 cl, 11 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY USING LIPOSOME-ASSOCIATED MELPHALAN IN AN EXPERIMENT | 2021 |
|
RU2772520C1 |
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY | 2014 |
|
RU2568368C1 |
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY IN RATS | 2014 |
|
RU2563368C1 |
| METHOD FOR SIMULATING PROLIFERATIVE RETINOPATHY IN RATS | 2014 |
|
RU2558991C1 |
| METHOD FOR PREVENTING PROLIFERATIVE VITRIORETINOPATHY DEVELOPING IN RETINAL DETACHMENT IN EXPERIMENT ON RATS | 2018 |
|
RU2689324C1 |
| METHOD FOR MODELING PROLIFERATIVE VITREORETINOPATHY | 2000 |
|
RU2182369C2 |
| METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 |
|
RU2161335C2 |
| METHOD OF PROPHYLAXIS OF PROLIFERATIVE TRANSFORMATIONS IN VITREOUS BODY IN EXPERIMENT | 1991 |
|
RU2008861C1 |
| METHOD FOR PREVENTING PROLIFERATIVE VITREORETINOPATHY | 1999 |
|
RU2175223C2 |
| METHOD FOR DETERMINING POSTOPERATIVE VISION ACUITY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT PATIENTS | 2004 |
|
RU2270596C2 |
